Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Finasteride helps reduce priapism in sickle cell anemia patients.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Finasteride can cause sexual problems and depression in young men.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Hair loss drugs may cause sexual issues and infertility in men.

Resveratrol helps prevent finasteride-induced damage in male rats, improving reproductive function.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Using existing drugs for new treatments is cost-effective and safer.

Early detection and removal of hair can prevent damage in hair-thread tourniquet syndrome.

Low testosterone may increase COVID-19 severity in men.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.